Invention Grant
US08193190B2 Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
有权
（桥连哌嗪基）-1-烷酮的衍生物及其作为p75抑制剂的用途
- Patent Title: Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
- Patent Title (中): （桥连哌嗪基）-1-烷酮的衍生物及其作为p75抑制剂的用途
-
Application No.: US12966413Application Date: 2010-12-13
-
Publication No.: US08193190B2Publication Date: 2012-06-05
- Inventor: Marco Baroni , Françoise Bono , Sandrine Delbary-Gossart
- Applicant: Marco Baroni , Françoise Bono , Sandrine Delbary-Gossart
- Applicant Address: FR Paris
- Assignee: Sanofi-Aventis
- Current Assignee: Sanofi-Aventis
- Current Assignee Address: FR Paris
- Agent Ronald G. Ort
- Priority: FR0803299 20080613
- Main IPC: A61K31/4995
- IPC: A61K31/4995
Abstract:
The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I): in which the variables are as defined herein, to the preparation thereof and to the therapeutic use thereof.
Public/Granted literature
- US20110144116A1 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS Public/Granted day:2011-06-16
Information query
